Core Wealth Advisors, Inc. Abbott Laboratories Transaction History

Core Wealth Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $5,862 - $7,176	-65 Reduced 24.53%	200 $22,000
Q1 2023 Apr 27, 2023	BUY	$96.86 - $114.01 $2,421 - $2,850	25 Added 10.42%	265 $26,000
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $3,802 - $4,460	40 Added 20.0%	240 $26,000
Q2 2021 Aug 03, 2021	SELL	$105.79 - $124.53 $6,982 - $8,218	-66 Reduced 24.81%	200 $23,000
Q4 2020 Feb 05, 2021	SELL	$105.0 - $114.42 $840 - $915	-8 Reduced 2.92%	266 $29,000
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $6,781 - $8,235	74 Added 37.0%	274 $30,000
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $15,702 - $17,480	200 New	200 $17,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Core Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Core Wealth Advisors, Inc. with notifications on news.